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Background 
Periodontal regeneration is defined as regeneration of the tooth-supporting 
tissues including cementum, periodontal ligament and alveolar bone. A potential 
tissue-engineering (TE) approach to periodontal regeneration involves the 
incorporation of progenitor cells and instructive messages in a prefabricated three-
dimensional construct and subsequent implantation of the construct into the defect 
site. The third generation guided tissue regeneration (GTR) membranes are based on 
the concept of TE. Biomaterials consist of biodegradable polymers and bioactive 
ceramics, are suitable for regenerative medicine. Chitosan, a biodegradable natural 
polymer and it possess excellent biological properties such as biocompatibility, 
antibacterial effect, and rapid healing capacity. It has several limitations including 
poor solubility under physiological conditions, to overcome these limitations, we 
focused on Chitosan derivative. Strontium, a trace element in the natural bones, can 
be substituted for calcium in hydroxyapatite, producing beneficial effects on bone, 
including stimulation of osteoblast differentiation, inhibition of osteoclast formation 
and bone resorption in-vitro. It also showed an excellent healing capacity. So we 
incorporating strontium in synthesized hydroxyapatite. Thus in this study an attempt 
is being made to fabricate new generation GTR membrane for periodontal tissue 
engineering application. 
Aim of this study  
The aim of this study was to fabricate GTR membrane of chitosan derivative 
and strontium apatite of varying concentration via freeze drying technique and 
comparing their in-vitro properties.  
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Materials and Methods 
GTR membranes made of chitosan derivative and strontium apatite of 
varying concentration via freeze drying technique and comparing their in-vitro 
properties. Morphological Properties analysed using scanning electron microscope 
(SEM).The mechanical properties such as tensile strength, elongation break and tear 
strength of samples were determined by using universal testing machine. Average 
membrane thickness was measured using thickness gauge. Chemical analysis are 
analysed using Fourier transformation infrared (FTIR)Spectroscopy In-vitro 
degradation  test of the scaffold were conducted by incubating the membrane in PBS 
at 37ºC  for 1,5,9,13,17,21,26 and 29days. Invitro bioactivity test of the scaffold 
were conducted by incubating the membrane in SBF at 37ºC for 3 and 7 days. 
Cytotoxicity assessment are observed using L-929 mouse fibroblasts. 
Result 
All the fabricated scaffolds were highly porous and had interconnected pore 
structure. The mechanical properties of fabricated membranes observed. Among 
these, chitosan derivative- strontium apatite membrane(7.5 mg and 10 mg ) possess 
increased thickness(mm)[0.50±0.02], chitosan derivative possess increased tensile 
strength and chitosan derivative- strontium apatite (7.5mg)exhibited highest tear 
strength(MPa)[0.65±0.05].Evaluating the chemical stability of the fabricated 
membrane by FTIR, results clearly indicate the strong bonding between chitosan 
derivative-strontium apatite composite membrane. For degradation analysis and in-
vitro bioactivity composite containing strontium apatite experienced higher weight 
loss. In cell culture composite membrane showed positive response to mouse 
Abstract 
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fibroblasts L929 cell attachment, here chitosan derivative-strontium apatite(7.5mg) 
(85.69%)exhibited enhanced viability than chitosan derivative. 
Conclusion 
From the observation of the study it was concluded that chitosan derivative -
strontium apatite composite membrane could be suitable for use as a GTR 
membrane. Further studies are needed for chitosan derivative -strontium apatite 
composite membrane for clinical use. 
Key words: Chitosan derivative, GTR membrane, Periodontal regeneration, 
strontium apatite.  
 
 
   
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Introduction 
 
   Page 1 
 
 
Periodontitis is an inflammatory disease of the periodontal tissues, caused by 
microorganisms and calculus accumulation on the bacterial biofilm, leading to 
degradation of the connective tissues and alveolar bone and subsequent formation of 
soft tissue pockets around the root surface. The ultimate goal of periodontal therapy 
is the regeneration of lost supporting tissues, the apical proliferation and migration 
of the epithelium must be prevented. It results in healing by development of long 
junctional epithelium, which precludes regeneration and results in repair.1According 
to a position paper by the American Academy of Periodontology, periodontal 
regenerative procedures include soft tissue grafts, bone replacement grafts, root 
biomodifications, guided tissue regeneration (GTR), and combinations  for osseous, 
furcation, and recession defects.2In the recent , attention has been focused more on 
regenerative and reconstructive therapies such as bone grafts, root conditioning, 
guided tissue regeneration,  growth factor. 
The term, guided tissue regeneration (GTR), was given by Gottlow in 1986. 
The theory of guided tissue regeneration is one that attempts to eliminate the apical 
proliferation of epithelium in support of other cells that will rise the chances of 
regeneration – bone and periodontal ligament (PDL).Guided tissue regeneration with 
barrier membranes has been proved to be effective in precluding epithelial and 
gingival connective tissue cells from migrating into the blood clot around the 
instrumented root surface. A physical barrier (membrane) is positioned to cover the 
region in which the regenerative process is to take place. In the space under the 
barrier, cells from periodontal ligament and bone colonize the blood clot, expressing 
their possibility for regeneration. The barrier membrane used for GTR can be 
commonly distributed into three generations of membranes. According to Gottlow’s 
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Classification (1993),first generation membrane (Non-resorbable),second generation 
membrane(Resorbable) and third generation membrane (Resorbable material with 
growth factor).3 
The first generation (non-absorbable) membrane, made from cellulose 
acetate (Millipore) was used as an occlusive membrane by Nyman et al.1982 .Later 
studies have exploited membranes of expanded polytetrafluoroethylene (e-PTFE) 
particularly designed for periodontal regeneration (Gore Tex Periodontal Material). 
Further non-resorbable barriers are titanium reinforced ePTFE, high-density-PTFE, 
or titanium mesh. Studies have revealed that titanium support of high-density PTFE 
membranes lead to superior regenerative capacity when associated to traditional 
expanded PTFE membranes normally due to the further mechanical support 
provided by the titanium frame against the compressive forces applied by the 
covering soft tissue .The main disadvantage is the required for second surgical 
procedure for the exclusion of the membrane.4 
The second generation (resorbable) membrane was aimed to avoid the 
requirement for surgical procedure. There are two common classifications of bio-
resorbable membranes: the natural and the synthetic membranes. Natural membranes 
are prepared of collagen or chitosan. Some complications, such as primary 
degradation, early loss of material, epithelial down growth along the material were 
informed after the use of collagen membranes. Synthetic materials made of 
polyesters e.g., poly glycolic acid (PGA) poly-caprolactone (PCL), poly lactic acid 
(PLA) and their copolymers were assessed. These materials are biocompatible, but 
by explanation they are not inert since some tissue reactions may be probable during 
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degradation which hypothetically influence wound healing and compromise 
regenerative result.4 
As the theory of tissue engineering(TE) has established, third-generation 
membranes have developed, which not only act as barrier membranes but also as 
delivery devices to discharge agents such as antibiotics, growth factors, adhesion 
factors etc, at the wound site on a time or essential basis in order to form and direct 
natural wound healing in an enhanced manner.4 They may be considered into the 
following sub divisions:- barrier membrane with growth factors, barrier membrane 
with antimicrobial activity and barrier membrane with bioactive materials.5 
The TE technology to bone and periodontal regeneration associates three key 
essentials to enhance regeneration, they are Conductive scaffolds/Extracellular 
matrix, Signalling molecules and Stem/Progenitor cells.6 This three dimensional 
extracellular architecture (scaffold) perform various functions, including the support 
of cell colonization, migration, growth and differentiation.7 It should have highly 
interconnected pores to stimulate cell ingrowth and distribution throughout the 
matrix, as well as enabling the increase of neovascularization. The minimum pore 
size is considered to be ~100–150 mm. Several methods have been used to prepare 
such interconnected porous structures, as for instance foaming, fiber extrusion and 
bonding, 3D  printing, phase separation, emulsion freeze-drying, porogen leaching, 
in situ pore forming, particle aggregation, electro spinning , supercritical fluids 
technology, and combinations of particles and cells.8  Of these ,freeze drying  most 
important technique  and is works on the principle of sublimation. This process is 
divided into three steps for its better understanding; they are Freezing, Primary and 
secondary drying.9 This technique has leads to form macroporous, interconnected 
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complex of polymer matrix that maintenances human osteoblast attachment and 
proliferation and timely onset of bone mineralization and resulting extracellular 
matrix deposition.10 
Biomaterials consist of bioactive and bio resorbable substances which 
imitate the natural purpose of bone and stimulate in-vivo mechanisms of tissue 
regeneration. Such composite substances based on biodegradable polymers and 
bioactive ceramics, are appropriate for regenerative medicine. 
Chitosan (poly-N-acetyl glucose aminoglycan), are the second most 
abundant natural carbohydrate biopolymer extracted from chitin. In recent times, 
importance in chitosan has increased due to its excellent biological properties such 
as biocompatibility,  rapid healing capacity and  antibacterial effect.11 Further 
benefits of chitosan scaffolds for bone  TE include the development of highly porous 
scaffolds with interconnected pores, osteoconductivity, and ability to improve bone 
development both in-vitro  and in-vivo. It has several drawbacks to be utilized in 
biological system, including its poor solubility below physiological conditions and 
lesser bioactivity. Therefore, to overcome these drawbacks, researchers concentrated 
on the derivation of Chitosan. 
In this present work, we trying to make it degradable as well as bioactive, so 
that modified chitosan will serve it function of guided tissue regeneration material 
according to normal physiological healing.  
Bone is a complex of organic and inorganic substances such as, nano-
crystallites, collagen fibrils and hydroxyapatite. Hydroxyapatite has ability to bind to 
both hard and soft connective tissues. It retains both osteoconductive and 
Introduction 
 
   Page 5 
 
 
osteogenetic properties. It consists of constituents such as phosphorus and calcium 
that prompt intracellular and extracellular reactions.12 Strontium, a trace element in 
the natural bones. It can be substituted for calcium in hydroxyapatite, creating 
favourable properties on bone, including inhibition of osteoclast formation, 
stimulation of osteoblast differentiation and bone resorption invitro. It also showed 
an excellent healing that exhibit new bone, cementum and functionally oriented 
periodontal ligament.13 So we are incorporating strontium in synthesized 
hydroxyapatite. Thus in our current study an attempt is being made to fabricate GTR 
membrane of chitosan derivative(CD) and strontium apatite(SA) of varying 
concentration  and comparing their in-vitro properties. 
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AIM OF THE STUDY  
The aim of the study was to fabricate chitosan derivative and strontium 
apatite composite sheets by the method of freeze drying which can be used for 
periodontal tissue engineering and to compare their in-vitro characteristics. 
OBJECTIVES OF THE STUDY 
• To fabricate the GTR membranes by incorporating varying concentration of 
strontium apatite (SA-7.5 mg and 10 mg) into chitosan derivative polymer by the 
method of freeze drying. 
• To characterize and compare the in-vitro morphological, mechanical and 
chemical properties of GTR membranes after their fabrication. 
• To evaluate the degradation behaviour of each membrane by incubating the 
membrane in Phosphate buffered saline (PBS) for 1, 5, 9, 13, 17, 21, 26 and 29 
days. 
• To evaluate the in-vitro bioactivity of each membrane by incubating the 
membrane in simulated body fluid (SBF) for 3 and 7 days. 
• To assess the cytotoxicity of fabricated composite sheets. 
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Guided tissue regeneration is a favourable application for repairing 
periodontal tissues, for using membranes by applying barrier membranes. According 
to a hypothesis formulated by Melcher14, certain cell populations exist in the 
periodontium have the potential to generate new cementum, alveolar bone and 
periodontal ligament, they have the opportunity to colonize the periodontal wound. 
The hypothesis was experimentally documented and histologically proved by 
Karringet al.15 The necessary for exclusion of epithelial and connective tissue cells 
of the gingiva from the wound led to development and use of GTR membranes. 
Bioaborbable membranes are made of a wide variety of materials, such as polylactic 
acid, polyurethane, collagen and chitosan.16 The natural biopolymer chitosan is 
presently a subject of attention in tissue engineering.17 
CHITOSAN 
Chitosan are the second most rich natural bio polymers, extracted from 
chitin. Chitosan and its derivatives  are commonly used for the preparation of the 
biodregradeble biomaterials. Chitosan of acetylation degree over 80% and average 
molecular wt nearby 350 kilo Dalton verified the foremost level of activity. It could 
be used as a base material for scaffold procedures and as modification outfits for 
presently used biomedical devices in improving tissue regeneration capability. It can 
develop the possibility of combinative approach of controlled drug release idea and 
tissue development in reconstructive therapy in the field of periodontics.18 
The following major features of chitosan make this polymer beneficial for 
numerous applications:19,20 
• It has a well-defined chemical structure. 
• It can be chemically and enzymatically modified. 
Review of Literature 
 
    Page 8 
 
• It is physically and biologically functional. 
• It is biodegradable and biocompatible. 
• It can be treated into several products including flakes, fine powders, 
beads, membranes, sponges, cottons, fibers, and gels. 
• It is non-toxic and safe to use. 
• It binds to microbial and mammalian cells.  
• It is, fungistatic, haemostatic and spermicidal agent. 
• It is anti-inflammatory agent and antitumor. 
• It accelerate bone regeneration. 
• It is immune adjuvant and drug delivery agent. 
Chitosan or chitosan-based composites have several unique properties for 
their use as a barrier membrane in GTR applications.21 Another biomaterial of 
attention is Hydroxyapatite, which is a major component of human bone. It is used 
as bone substitute in the fields of dentistry and orthopaedics because of its good 
bioactivity, osteo conductivity and biocompatibility. But it is brittle and easy to 
fracture so it is hard to mould into a definite shape. In this study we incorporating 
strontium in hydroxyapatite in order to overcome limitations of hydroxyapatite.22 
Composites containing hydroxyapatite and natural biopolymers ,chitosan are 
commonly used as biomaterials for TE. These materials combine the ultimate 
bioactive and natural polymer composited which imitates natural bone functions and 
stimulates in-vivo tissue regeneration mechanism. Therefore, a composite 
biomaterial of strontium apatite and chitosan derivative is estimated to show 
increased osteoconductivity, biocompactible, excellent healing capacity and 
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biodegradation together with adequate mechanical strength. So many fabrication 
technologies have been functionalized to process biodegradable and bioresorbable 
materials for TE into 3D polymeric scaffolds of high porosity and surface area. The 
conventional techniques for scaffold fabrication contain fiber bonding ,particulate 
leaching, membrane lamination, solvent casting, and melt molding, freeze-drying 
method etc. Among these we fabricated by using freeze drying method. The freeze-
drying method for scaffold fabrication has give rise to macroporous, interconnected 
network of polymer matrix that maintenances human osteoblast attachment and 
proliferation ,early onset of bone mineralization and following extracellular matrix 
deposition.22 
CHITOSAN-HYDROXIAPATITE COMPOSITE MEMBRANES 
Yin et al in 2000,23 prepared a composite composed of HA and a complex 
made by crosslinking of chitosan and gelatin with glutaraldehyde was established by 
sol-gel method. Chitosan sol was made by dissolving chitosan in aqueous acetic acid 
solution by stirring 24 h at room temperature. A glutaraldehyde solution was 
prepared by dissolving it in water. Hydroxyapatite powder was added in deionized 
distilled water and ultrasonicated until the HA powder was distributed in water. The 
slurry was held for 5h to let hydroxyapatite powder deposit. Then this deposited 
paste mixed with a chitosan solution below agitation .After gelatin was added  and 
allow to dissolving of gelatin glutaraldehyde aqueous solution. Finally the resultant 
mixture with equally distributed HA powder  and was transformed into a mold then 
air dried inorder to obtain composite plate. HA content is changed to handle 
composites with different hydroxyapatite  percentage weight. 
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Zhao et al in 2002,24  studied the preparation of 3D hydroxyapatite-chitosan-
gelatin complex composite scaffolds designed by phase separation system. A 
suspension was made by using hydroxyapatite and deionized water. After 0.5 hour 
stirring at room temperature the mixture was preserved ultrasonically until the HA 
powder was carefully dispersed in the deionized water. Then chitosan and acetic 
acid were added. After stirring overnight gelatin was added to this suspension held 
in 40C̊ water bath. Then addition of a glutaraldehyde solution it was put into plastic 
petri dishes at 40 ̊C half an hour then quickly removed to a freezer at –40oC to freeze 
the solvent and make solid-liquid phase separation. The mixture was retained at that 
temperature for 2 hours. And finally placed in a freeze-drier, freeze-dried for at least 
30h obtaining in a foam which were cut into disks. Varying the HA content and the 
compositional variables of the new mixture allowed densities of the scaffold and 
control of the porosities . 
Yamaguchi et al in 200325, fabricated HA/ chitosan composites using a co 
precipitation method. A chitosan solution of 1.5 weight % made by mixing chitosan 
powder into distilled water enclosing 0.6 weight % of acetic acid and the chitosan 
solution was adding into 8.5 weight % of phosphoric acid solution. The attained 
chitosan/ phosphoric acid solution was slowly dropped into 3.7 weight % calcium 
hydroxide suspension stirring till pH 9±0.2. During this stage chitosan became 
insoluble and precipitated with small HA crystals forming chitosan/HA composite. 
The  temperature was at 25 ̊C and releasing speed was 3.2 ml/min. The resultant 
mixture was aged for 24 hours upon constant stirring. The preparation of 
chitosan/hydroxyapatite composite using citric acid was as an aqueous solution of 
50wt% citric acid was mixed  into a mixture of chitosan -hydroxyapatite (20/80) 
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complex. Then the obtained mixture was then aged for 24h. Finally the precipitate 
was filtered and washed by distilled water. The outcome of citric acid on mechanical 
properties of the composite were examined. 
Park J.S et al in 2003,26 assessed the periodontal tissue regenerative effects 
of a chitosan/ collagen sponge applied to preclinical intrabony defects surgically 
formed in beagle dogs. In this study 4mm intrabony defects were surgically 
generated in the bilateral maxillary first and third, the mandibular second and fourth 
premolars. The surgical control group received a flap operation only, while the 
buffer control group was treated afterwards with a PBS/collagen sponge and the 
chitosan group was cured with a chitosan/collagen sponge . They were killed 8 
weeks after the operation, and a comparative histological examination was achieved. 
The consequences demonstrate the favorable effect of the chitosan/collagen sponge 
on the intrabony defects of beagle dogs. The inhibited apical migration of epithelium 
and the rise in the amount of new bone and cementum advocate the effectiveness of 
chitosan in periodontal regeneration. 
Ta Wei Chen et al in 2004,27 prepared chitosan membranes by a thermal 
induced phase separation method, resulting treatment with nontoxic sodium 
hydroxide gelating and sodium triphosphate, sodium sulphite crosslinking agents. 
Effects of these reaction agents on chitosan membranes were assessed to survey the 
feasibility of using these membranes in GTR application. The primary results 
revealed chitosan membranes cross linked with sodium triphosphate and sodium 
sulphite had gel content of 53.5% and 52.2%r, respectively. The chitosan matrix 
gelated with sodium hydroxide dissolved totally during gel content measurement. 
Chitosan membrane treated with sodium triphosphate had lowest elastic modulus of 
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12.9 Mpa (Megapascal) as associated with other membranes treated with sodium 
sulphite(17.9Mpa) and sodium hydroxide (23.6Mpa). From SEM observations, 
sodium hydroxide gelated chitosan membrane had the smoothest surface 
morphology than others. Nevertheless, sodium triphosphate cross linked chitosan 
membrane had better cell adhesion and proliferation effects in cell culture test. All  
chitosan membranes degraded by about 23%~28% of initial weight after a 90-day in 
vitro shaking test. This study described that chitosan membranes were used as a 
barrier membrane for GTR. 
K.H. Im et al in 2005, 28 fabricated organic and inorganic scaffolds by solid-
liquid phase separation and following sublimation of solvent based on HA. The 
morphological and mechanical properties of the scaffolds were measured by varying 
content of HA. The bioactivity was assessed after scaffolds were occupied into 
Simulated body fluid during 7 days. This study reported that desirable pore 
structure, mechanical properties, and bioactivity of the hybrid scaffolds attained 
through controlling the ratio of HA and chitosan. 
Zhang et alin 2005,29 prepared and characterized nano-hydroxyapatite/ 
chitosan composite scaffolds. The nano-hydroxyapatite particles were made through 
a chemical method. They bound to the chitosan scaffolds very well. This method 
avoids the migration of nano-HA particles into surrounding tissues to a certain level. 
The morphologies, components, and biocompatibility of the composite scaffolds 
were examined. SEM, porosity measurement, thermogravimetric analysis, X-ray 
diffraction, X ray photoelectron spectroscopy, and FTIR were used to analyze the 
physical and chemical properties of the composite scaffolds. The biocompatibility 
was assessed .The composite scaffolds revealed better biocompatibility than pure 
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chitosan scaffolds. The effects advocate that the newly developed nano-HA/chitosan 
composite scaffolds may help as a good three-dimensional substrate for cell 
attachment and migration in bone TE.  
Shyh Ming Kuo et al in 2006, 30 assessed chitosan as barrier membrane for 
GTR application. Three types of chitosan membranes ,each was gelated by sodium 
hydroxide, crosslinked by sodium phosphoric acid and sodium sulphite, were 
prepared to be evaluated by the following classifications: the mechanical strength to 
generate an effective space, the rapid rate to reach hydrolytic equilibrium in 
phosphate-buffered solution, and the ease of clinical manipulative operations. 
Therefore, standardized, trans osseous and critical sized skull defects were made in 
adult rats and the defective regions were enclosed with the specifically prepared 
chitosan membranes. After 4 weeks of recovering, varying degrees of bone healing 
were detected beneath the chitosan membranes in contrast to the control group. This 
study concluded that chitosan membranes were apparently suitable for GTR. 
Ismail Zainol et al in 2008,31prepared and characterized water soluble 
chitosan(WSCH)/nano hydroxyapatite(nano-HA) composites using mixing 
technique.30% glycerol was added to produce flexible composite. The WSCH/nano-
HA composites was prepared using casting and drying process. The composite was 
characterized using scanning electron microscope, X-ray diffraction and Fourier-
Transformed Infrared spectroscopy to regulate the morphology of the composites 
and to finalize the presence of hydroxyapatite in the composites. Results showed 
that hydroxyapatite was distributed homogeneously in water soluble chitoson 
matrix. The mechanical properties of the composite were verified using Universal 
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Testing Machine. It was found that increasing nano-HA content in the composite 
will decrease the tensile strength. 
Jung-A Shin et al in 2009,32 assessed the effect of hydroxyapatite 
(HA)-chitosan (CS) membrane on bone regeneration in the rat calvarial defect. 
The consequence of this study is Surgical implantation of the HA - CS 
membrane resulted in improved local bone formation at both 2 and 8 weeks 
associated to the control group. The hydroxyapatite and chitosan membrane 
would be additional effective than the chitosan membrane in initial bone 
formation. They concluded the HA-CS sheath would be an effective biomaterial 
for periodontal bone regeneration.  
TarunGarg et al in 2012,33 Prepared Chitosan Scaffolds for TE using 
Freeze drying Technology. The morphology and size of the scaffold preparations 
were observed using scanning electron microscopy. They concluded that  the 
viability of processing chitosan 3D scaffolds for TE applications using freeze 
drying technology. Freeze drying technology was used to precipitate chitosan from 
acetic acid solutions and used effectively as a drug delivery carrier, able to transfer 
active agents or biomolecules and growth factors. 
Sun Mizo et al in 2012,9 described fabrication of chitosan– 
hydroxyapatite macroporous interconnected structure along with the polymers, 
rheological properties of the material, cell proliferation and chemical bonding, 
alkaline phosphatase activity of the macroporous scaffold considered using 
freeze-drying method. SEM study exhibited macroporous architecture with 
interconnected pores. Elemental analysis evidently specified presence of calcium, 
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phosphorus and sodium along with oxygen and nitrogen in the scaffold. The 
FTIR examination indicated chemical bonding between both the polymers. The 
rheological testing was accomplished which exhibited no significant change. 
Human osteoblast seeded on CS–HA matrices showed viability for longer period 
of time and greater cellular proliferation .Rise in mineral deposition was 
examined using alkaline phosphatase assay which confirmed that CS–HA 
scaffold provided conducive environment for osteoblast proliferation and mineral 
deposition. The morphological and mechanical properties of the scaffold were 
found to be crucial for bone TE. 
H. R. LE et al in 2012,34 fabricated and evaluated the mechanical properties 
of chitosan composite membrane containing hydroxyapatite particles. The properties 
of hydroxyapatite content on the microstructure and mechanical properties of 
composites were observed. It was found that the Young’s Modulus of the 
composites declines with hydroxyapatite content while the failure strength and strain 
rise with the hydroxyapatite content. 
Huang Yet al in 2013,35 prepared CS and strontium-substituted HA films on 
titanium. FTIR features by electrochemical deposition method containing strontium, 
Phosphate ,Calcium and Chitosan. The prepared coatings were observed by scanning 
electron microscop, energy-dispersive X-ray spectroscopy, FTIR and XRD 
investigations. The results specify that the CS/Strontium HA coatings ,morphology 
of flake-like rather than the needle-like crystal .The FTIR assessment shows that the 
typical vibration absorption peaks of chitosan emerged, SBF immersion test showed 
that the CS/Strontium HA coatings had encouraged carbonate-apatite development, 
demonstrating that the composite coating keeps good biocompatibility. In the 
Review of Literature 
 
    Page 16 
 
electrochemical corrosion analysis, that the CHI/Strontium HA coatings exhibited 
stronger corrosion resistance than pure Titanium. 
P.A. Norowski et al in 2012,36 in his study, electrospun chitosan 
membranes, cross-linked with 5 mM or 10 Mm geinipin, a natural crosslinker 
extracted from the gardenia plant, were assessed for suture pullout strength, 
crystallinity, and cytocompatibility. Ultimate suture pullout strength was 
considerably lower (51–67%) than that of commercially available collagen 
membranes. Crystallinity of the electrospun chitosan membranes decreased upon 
crosslinking by 14–17%. The molecular weight of the chitosan polymer was reduced 
by 75% during the electrospinning process. Uncross linked and genipin-cross linked 
chitosan membranes were cytocompatible and maintained fibroblast cell 
proliferation for 9 days. Uncross linked and genipin- crosslinked membranes did not 
stimulate monocytes to produce nitric oxide in vitro in the absence of 
lipopolysaccharide. In conclusion, chitosan membranes inhibited 
lipopolysaccharide- induced Nitric oxide production by 59–67% as compared to 
tissue culture plastic and collagen membrane. Advances are necessary in the tear 
strength of electrospun chitosan membranes for clinical application. 
Kimberly T et al in 2013,37 assessed the feasibility of the hydroxyapatite–
chitosan–gelatin  composite as a barrier GTR membrane by examining the interfaces 
of the hydroxyapatite–chitosan–gelatin membrane with serum proteins and their 
following effects on Human mesenchymal stem or stromal cells properties. The 
results reveal hydroxyapatite–chitosan–gelatin prominent capacity to improve with 
extracellular matrix proteins, forming instructive microenvironments that encourage 
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Human mesenchymal stem or stromal cells proliferation and the advance of 
osteogenic differentiation. 
Tao Sun et al in 2014,38 fabricated chitosan and HA/chitosan scaffolds  
with desired pore sizes and porosity using thermally induced phase separation 
technique. The scaffolds were characterized using various methods. The invitro 
degradation and the response of fibroblast cells on porous chitosan-based 
scaffolds were also assessed. The scaffolds were highly porous and had 
interconnected pore structures. The combined HA nanoparticles were well 
mixed and physically existed with chitosan in composite scaffold structures. 
The addition of 10% HA nanoparticles to chitosan improved the compressive 
mechanical properties of composite scaffold related to pure chitosan scaffold. 
In vitro degradation effects in phosphate buffered saline (PBS) shown slower 
uptake properties of composite scaffolds. Moreover, the scaffolds showed 
positive reaction to mouse fibroblast L929 cells attachment. Generally, the 
findings advocate that HA/chitosan composite scaffolds could be suitable for 
TE applications. 
L. Pighinelli, M. Kucharskain 2014,39 fabricated preparation of certain forms 
of the early chitosan like microcrystalline chitosan, physico-chemical characterization, 
elaboration of the method for preparation composites with microcrystalline chitosan 
and hydroxyapatite. To increase the suitability of chitosan and its derivatives for bone 
TE, the composites of microcrystalline chitosan and hydroxyapatite could be applied. 
They determined that the sponge preparations with hydroxyapatite and 
microcrystalline chitosan formed a 3-D structure which can be used in future as a base 
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for scaffolds . The HA  aggregates well in the polymer matrix of microcrystalline 
chitosan showing a standardised construction and distribution in the polymer matrix. 
Bavariya AJ et al in 2014,40 assessed biocompatibility and degradation of 
chitosan nanofiber membranes, with and without genipin crosslinking as related 
with a commercial collagen membrane in rat model which were inserted 
subcutaneously in the backs of 30 rats. The membranes were inspected 
histologically at 2, 4, 8, 12, 16, and 20 weeks. Sections were observed and graded by 
a blinded pathologist using a 4-point scoring system  to decide the tissue reaction to 
the membranes and to detect membrane degradation. There was no statistically 
significant difference in histological scores between chitosan and collagen 
membranes at different time points. Absence or minimal inflammation was detected 
in 57–74% of the membranes across all groups. Most collagen membranes gone by 
resorption at 12–16 weeks. The general tissue reaction was related to that of control 
commercial collagen membrane. Still, the chitosan membranes exhibited slower 
degradation rates than collagen membranes. 
Diana Marcela Escobar-Sierra et al in 2015,41 fabricated chitosan/ 
hydroxyapatite scaffolds, using various ratios and two different techniques. The 
powder hydroxyapatite (commercial) and in situ hydroxyapatite, and then compare 
their properties. The morphology, chemical composition and mechanical properties 
were assessed by Scanning Electron Microscopy ,X-ray diffraction and compression 
tests. The scaffolds  showed an interconnected porous structure. The scaffolds with 
chitosan and hydroxyapatite developed by in situ protocol, have improved 
applications inTE, because they have a better morphology and allow the cell growth. 
Nitin Sahai et al in 2015,42 fabricated and characterized scaffolds (PCL, HA, 
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PGA& Chitosan)for tissue engineering applications. The actual mechanical 
strength/properties like stress and strain fall with the rise of the porosity for all three 
scaffolding biomaterials (HA, PCL, PGA). Chitosan scaffold displays same type 
deviation in there mechanical properties as with the rise in its porosity its 
mechanical properties declines but the mechanical strength of the Chitosan is very 
low. Lyophilization and Freeze drying are the techniques are used to create the 
porous chitosan tissue scaffold through which the size of porous tissue scaffold is 
controlled which will be supportive in fabrication of correct mechanical strength 
tissue scaffold. 
               Tu Ying et al in 2017,43 fabricated an asymmetric nano-hydroxyapatite/ 
chitosan (n-HA/CS) composite GBR membrane was by means of solution-blending 
and solvent-evaporating in vacuum. The membranes were analysed using SEM, XPS 
and contact angle. It was create that the composite membrane displayed an 
asymmetric structure, in which the upper surface was CS and the under surface was 
a complex of n-HA and CS, and some relations between n-HA and CS were also 
confirmed to exist. The contact angle testing exhibited that the under surface was 
more hydrophilic than the upper surface. The in- vivo experiments revealed that the 
asymmetric composite membrane had the capability to make osteoblasts mineralize 
and support loose bone calcified, and then speed up the bone regeneration. 
Compared with CS membrane, the asymmetric composite membrane shows a better 
bone regeneration ability and is proper for GBR membrane. 
          Sang Min Park et al in 2017,44 prepared composite membrane by blending 
acetylated chitosan with carbonated nano-size hydroxyapatite for use as a GTR 
barrier. The carbonate group of CHAP was a partial replacement of the hydroxyl 
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group and/or phosphate group of hydroxyapatite by sintering with carbon dioxide. 
Chitosan/CHAP complexes were acetylated with acetic anhydride to form the 
ACS/CHAP composites. The compositions and properties of the composites were 
confirmed by FTIR, inductively coupled plasma mass spectrometry, zeta potential 
analysis, X-ray diffraction analysis, UTM analysis, SEM, MTT assay, etc. The 
surface energies of the composites were improved by carbonation and acetylation. 
The acetylation of chitosan better the lysozyme degradation of the composite. The 
carbonation of hydroxyapatite significantly improved the viability of osteoblast-like 
cell on the composite. The high viability and intact phenotype of cell occurred on 
composite with ACS/CHAP ratio of 50/50, which had adequate elastic modulus for 
a GBR barrier. 
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The study protocol was approved by Institutional Research Committee(IRC) 
with Ref no.11/07/2016 and Institutional Human Ethics Committee(IHEC) protocol 
no 13/2016, Sree Mookambika Institute Of Dental Sciences Kulasekharam, 
Kanyakumari Dist, Tamil Nadu. Laboratory facilities for this study was provided by 
Bioceramics  division, Biomedical technology wing of Sree Chitra Thirunal Institute  
of Medical Science and Technology, Trivandrum, India for a period of 6 months. 
MATERIALS 
• Group I - Chitosan derivative 
• Group II - Chitosan-Strontium Apatite Composite (7.5 mg ) 
• Group III - Chitosan-Strontium Apatite Composite (10  mg ) 
For membrane fabrication 
 Chitosan [India Products, India] [CP-1] 
 Strontium apatite (wet precipitate of calcium and phosphate salt) 
[Bioceramics division, Sree Chitra Thirunal Institute of Medical Science and 
Technology, Trivandrum][CP-2] 
 Glycidyltrimethyl ammonium chloride(GTMAC)[Sigma Aldrich Pvt Ltd., USA] 
 Acetic acid(CH3COOH) [Sigma Aldrich Pvt Ltd., USA][CP-3] 
 Methanol (Merck EMPARTA® Pvt Ltd USA)[CP-4]. 
 Conical flask containing magnetic bead (Bioceramics division, Sree Chitra 
Thirunal Institute of Medical Science and Technology, Trivandrum)[CP-5] 
 Dialysis membrane (spectra/Por molecular porous membrane)[CP-6] 
 Automatic stirrer (IKA C-MAG HS 7 digital Pvt Ltd, USA)[CP-7] 
 Electronic weighing machine (Scaletec Mechanotronics Pvt Ltd, India)[CP-8]. 
 Freeze dryer (Benchtop SLC Pvt. Ltd. UK)[CP-9]. 
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For analysing morphology 
 Scanning electron microscope (Hitachi –model-s-2400, JEOL, JSM-6390, 
model 7582, Japan)[CP-10]. 
 Image J software. 
For analysing mechanical strength 
 Thickness Guage [CP-11]. 
 Universal testing machine (instron3345 single column, UK: software-
bluehill3)[CP-12]. 
For chemical analysis (presence of functional groups) 
 FTIR Spectrometer[CP-13] 
For analyzing in-vitro degradation and in-vitro bioactivity 
 PBS with PH of 7.4 [Bioceramics division, Sree Chitra Thirunal Institute of 
Medical Science and Technology, Trivandrum]. 
 SBF [Bioceramics division, Sree Chitra Thirunal Institute of Medical 
Science and Technology, Trivandrum]. 
For cytotoxicity assessment 
 UV irradiator for sterilization of samples (Biogenix Research Center, 
Trivandrum, India). 
 Mouse fibroblast L929 cells (National Centre for Cell Science, Pune, India). 
 Dulbecos Modified Eagles Medium (Biogenix Research Center, Trivandrum, 
India). 
 Phase Contrast Microscope [CP-14](Olympus CKX41) for MTT assay 
observation provided by Biogenix Research Center ,Trivandrum, India. 
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 Imaging software Optika vision-pro. 
 Succinate dehydrogenase enzyme (SDH) [Biogenix Research Center, 
Trivandrum, India]. 
 PBS with PH of 7.4 [Bioceramics division, Sree Chitra Thirunal Institute  of 
Medical Science and Technology, Trivandrum]. 
METHOD OF GTR MEMBRANE FABRICATION 
The method employed in this study have been divided into following steps,  
• Preparation of modified chitosan  
• Preparation of strontium apatite containing chitosan membrane. 
(1)Preparation of modified chitosan 
2% chitosan solution was prepared by dissolving 1 gm purified chitosan in 
50 ml, 2% acetic acid stirred overnight .When it was completely dissolved in acetic 
acid heated to 80 C̊ and 0.75 mL glycidyltrimethyl ammonium chloride was added,  
stirred at 80C̊ for 7 hours in a conical flask containing magnetic bead. After 7hrs it 
was allowed to reach at room temperature and then precipitated in 150 ml acetone. 
The precipitate was filtered and washed with methanol. The precipitate again 
washed two times with methanol, filtered and dialysed for 24 hrs[CP-15]. 
 (2) Preparation of the chitosan derivative/strontium apatite composite 
  Composite scaffold were synthesized with chitosan derivative and strontium 
apatite of varying concentrations (SA-7.5 mg and 10 mg). Strontium apatite powder 
was dispersed in deionized water for 2 hour. Subsequently suspention was added 
drop by drop to the chitosan solution(7.5 mg   and 10 mg of strontium apatite in 
chitosan solution of 5 ml in each beaker).Next, the chitosan derivative/strontium 
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apatite  suspension vigorously mixed using a magnetic stirrer for 2 hours to obtain 
homogenous mixture and  it was transferred to containers, frozen and lyophilized for 
24 hours[CP-16]. 
FOR ANALYSING MORPHOLOGY 
The morphology of the composite sheets was observed by Scanning electron 
microscopy(Hitachi –model-s-2400,JEOL,JSM-6390 ,model 7582,Japan).The 
samples were dried and was coated with gold and analysed under scanning electron 
microscope (20 kv). 
MEMBRANE THICKNESS 
Average membrane thickness was measured using thickness guage[CP-
11].The average thickness of the membrane at five random position was adopted as 
the mean thickness of the membrane. 
FOR ANALYSING MECHANICAL PROPERTIES 
The mechanical properties such as tensile strength and elongation break of 
samples were determined by using universal testing machine (Instron 3345,single 
column, UK: software –blue hill 3).A load cell of 100 N was hammered vertically at 
the speed of 5 mm/min on a membrane sample of 1x6cm.The tensile strength 
measurements were charted up to the point where they were broken[CP-17]. 
SUTURE PULLOUT STRENGTH  
Suture pull out tests were analysed to determine the tear strength of the   
sheets. Membrane specimens were prepared to be 10 mm wide and about 40 mm 
long. A single suture was made 5 mm from the top edge and 5 mm from each side. 
The suture was a 70 cm general closure monofilament silk with taper ct-1 needle and 
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1 (4.0 metric) gauge. The suture was left un-knotted but was affixed to the upper 
claw of the Instron TM model 3345, mechanical test frame .Suture pull out testing of 
dry specimens was carried out with a 50 N load cell and an extension rate of 1 
mm/min.[CP-18]. 
CHEMICAL CHARACTERISATION OF SCAFFOLDS 
The presence of strontium apatite on composite sheets was analysed using 
FTIR.  
IN-VITRO DEGRADATION TEST 
In-vitro degradation  test of the scaffold were conducted by incubating the 
membrane in PBS at 37ºC for 1,5,9,13,17,21,26 and 29days.For weight loss studies 
circular samples with 20mm diameter where incubated in a closed bottle containing 
30ml phosphate buffered saline(PBS) having pH of 7.4 at 37ºC. The initial weight of 
the membrane before incubating in the PBS was measured and the membranes 
retrieved after 29 days. The retrieved membranes were washed with deionized 
water, dried in vaccum oven and weighed until constant weight is attained. The 
percentage weight loss was estimated using the equation, 
  Weight loss (%)=(Wi-Wf)/Wi×100 
IN-VITRO BIOACTIVITY TEST 
Invitro bioactivity test of the scaffold were conducted by incubating the 
membrane in SBF at 37ºC for 3 and 7 days. For analysing weight difference circular 
samples with 20mm diameter where incubated in a closed bottle containing 30ml 
SBF at 37ºC. The initial weight of the membrane before incubating in the SBF was 
measured for 3 and 7 days and the membranes retrieved after 3 and 7 days. The 
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retrieved membranes were washed with deionized water, dried in vaccum oven 
weighed until constant weight is attained. 
DETERMINATION OF TOXICITY 
Cell culture 
For biological evaluation, mouse fibroblast L929 cells were procured from 
the National Centre for Cell Science, Pune, India. The cells were grown in DMEM 
supplemented with 10% FBS and containing the antibiotics penicillin, streptomycin 
and amphotericin B (5000 units) in a humidified incubator at 5%CO2 at 37 ± 0.20C. 
The cells were regularly monitored by phase contrast inverted light microscopy. The 
medium was changed once in three days. The confluent monolayer was sub-cultured 
and maintained for further studies 
Sample preparation 
Samples were exposed in Ultraviolet irradiation (Biogenix Research Center, 
Trivandrum, India) for 30 minutes and was directly taken for the analysis. 
Evaluation of the toxicity of material extracts by MTT assay 
The cytotoxicity of material was evaluated as per ISO10993-5 on L-929 
mouse fibroblast cell culture. The cells were seeded onto a 48 well plate and 
incubated. After attaining confluency, the sterile material was added to the cell 
seeded plate. The percentage of the surviving fibroblast cells were quantified by the 
MTT assay and the morphological changes of the cells were monitored by phase 
contrast microscopy. 
MTT assay is carried out to measure mitochondrial cellular metabolism 
(viability) and number of viable cells. MTT assay is based on the capability of 
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metabolically active fibroblast cells to reduce the yellow water-soluble tetrazolium 
salt (MTT) to purple formazan crystals using the mitochondrial enzyme succinate 
dehydrogenase (SDH). The intensity of purple colour so formed is proportional to 
the number of viable cells. Following the experiment the culture was washed with 1 
x PBS and then 200 µl MTT solution per ml culture (MTT 5 mg/ml dissolved in 
PBS and filtered through a 0.2 µm filter before use) were added. The whole content 
was again incubated at 37oC for 3h and 300 µl DMSO were added to each culture 
well. The whole content was incubated at room temperature for 30 min until all cells 
were lysed and a homogenous colour was obtained. The solution was centrifuged for 
2 min to sediment cell debris. The optical density (OD) was measured 
spectrophotometrically at 540 nm. Cells treated with MTT solution without sample  
was used as control. The percentage viability was calculated as follows.  
%	Viability	 =
OD	of	test	
OD	of	control	
		100 
Direct contact method 
The cytotoxicity of materials under the direct contact of cell was determined 
by direct contact assay.L929 fibroblast cells(1x104 cells/m) were seeded on to a well 
plate(3D Falcon) and allowed to proliferate to 24hrs to form a sub-confluent layer. 
Then the material (1cm diameter) was placed over the monolayer and allowed to 
proliferate for 24 hrs in a CO2 incubator. After the incubation, cells were evaluated for 
changes in morphology with respect to control(cells grown  without materials) under 
inverted phase contrast microscope(Olympus CKX41) attached with an imaging 
camera. The images were captured using imaging software Optika vision-pro. 
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STATISTICAL ANALYSIS 
The data is expressed in mean and standard deviation. Statistical package for 
social sciences(16.0)version used for analysis. ANOVA, POST HOC followed by 
dunnet t test applied to find the statistical significant between the groups. p value 
less than 0.05(p<0.05)considered statistically significant at 95% confidence interval. 
Group I-Chitosan derivative 
Group II -Chitosan-Strontium Apatite Composite (7.5 mg) 
Group III-Chitosan-Strontium Apatite Composite (10  mg ) 
1. MORPHOLOGICAL ANALYSIS 
The morphology of the composite scaffold was examined with SEM.  
Image1a and 1b shows SEM images of Chitosan derivative under low 
magnification(200x) and high magnification (400x).It was showed high porosity and 
good inter pore connectivity  with macropores of around 300µm for 400x and 500 
µm for 200x and a lot of micropores. Image 2a,and 2b shows SEM images of 
chitosan derivative/strontium apatite composite membrane (7.5 mg) under low 
magnification(200x) and high magnification (400x).It was observed pore sizes of 
around 500µm and 300 µm. A good distribution of strontium apatite on the surface 
of scaffold s is also observed. Image 3a and 3b shows SEM images of chitosan 
derivative/strontium apatite composite membrane (10mg) under low 
magnification(200x) and high magnification (400x). Scaffold showed pore sizes 
300µm and 500 µm. A good distribution of strontium apatite on the surface of 
scaffolds is also observed. 
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SEM IMAGES OF FABRICATED GTR MEMBRANES WITH DIFFERENT 
MAGNIFICATIONS 
 
CHITOSAN DERIVATIVE 
 
       
Image 1a                                                   Image 1b 
 
CHITOSAN-STRONTIUM APATITE COMPOSITE(7.5 MG ) 
                     
Image 2a                                                    Image 2b 
CHITOSAN-STRONTIUM APATITE COMPOSITE(10 MG) 
 
           
Image 3a                                                   Image 3b 
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2. MEMBRANE THICKNESS 
Table-1: Comparison of mean membrane thickness(mm) values between the 
groups  
Groups Treatment Thickness (mm) (MEAN±SD) 
Group-I Chitosan derivative 0.25±0.01 
Group-II Chitosan-strontium apatite Composite (7.5 mg) 0.49±0.02* 
Group-III Chitosan-strontium apatite Composite(10 mg) 0.50±0.02* 
(*p<0.05 significant compared Group-I with other groups, p>0.05 no significant 
difference compared Group-II with Group-III) 
 
Table 1 shows Comparison of mean thickness values between the groups. 
Among this group I showed least thickness 0.25±0.01 when compared with group II 
[0.49±0.02] and group III [0.50±0.02] respectively and was not statistically 
significant compared with other groups. Group III shows highest thickness 
[0.50±0.02 ]  and was statistically significant with group II. Overall there was an 
increase in thickness with the increase in weight of concentration of strontium 
apatite particles in composite membrane. 
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3. MECHANICAL PROPERTIES 
Table-2: Multiple comparison of mean tensile strength (MPa) and elongation at 
break (%) (mm/mm) values between the groups   
Groups Tensile strength (MPa)  (MEAN±SD) 
Elongation at break (%) 
(mm/mm) (MEAN±SD) 
Group-I 2.91±0.52 0.07±0.02 
Group-II 0.47±0.13* 0.11±0.03* 
Group-III 0.55±0.17* 0.12±0.01* 
(*p<0.05 significant compared Group-I with other groups, p>0.05 no significant 
difference compared Group-II with other groups) 
 
Table 2 shows Comparison of mean tensile strength  and elongation at break 
value of between the groups. Among this group I showed no statistical significant 
when compared with group I and group III. Where group II was compared there was 
no statistical significant seen with group I and was statistical significant with group 
III. When group III was compared no statistical significant seen with group I and 
was statistical significant with group II. 
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4. SUTURE PULLOUT STRENGTH  
Table-3: Multiple comparison of mean suture pull out strength values between 
the groups  
Groups Treatment 
Suture pull out 
strength (MPa) 
(MEAN±SD) 
Group-I Chitosan derivative 0.31±0.11 
Group-II Chitosan-strontium apatite Composite(7.5 mg) 0.65±0.05* 
Group-III Chitosan-strontium apatite Composite(10 mg) 0.60±0.20* 
(*p<0.05 significant compared Group-I with other groups, p>0.05 no significant 
difference compared Group-II with Group-III) 
 
Table 3 shows multiple comparison of mean tear strength values between the 
groups. Among this group I showed no statistical significant when compared with 
group I and group III. Where group II was compared there was no statistical 
significant seen with group I and was statistical significant with group III. When 
group III was compared no statistical significant seen with group I and was 
statistical significant with group II. 
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5. CHEMICAL CHARACTERISATION OF SCAFFOLDS  
FTIR Analysis 
FTIR spectra   was observed at 4000 cm-1 to 500cm-1, and different OH 
stretching was observed as: OH-NH vibration of  chitosan alone at 3348cm-
1,chitosan derivative at 3351cm-1,  chitosan with 7.5 mg strontium apatite at 3285 
cm-1 and 10mg strontium apatite at 3294cm-1.CH vibration of CH2 and CH3: 
chitosan alone at 2919.9 cm-1,chitosan derivative at 2877.2cm-1, chitosan with 7.5 
mg strontium apatite at 2877.4 cm-1 and 10mg strontium apatite at 2877.1 cm-
1.C=O stretching: chitosan alone at 1626.4cm-1,chitosan derivative at 1630.1cm-1,  
chitosan with 7.5 mg strontium apatite at 1633.3 cm-1 and 10mg strontium apatite at 
1639.9cm-1.C-O-C group : chitosan alone at 1149.7cm-1,chitosan derivative at 
1151.2cm-1,  chitosan with 7.5 mg strontium apatite at 1151.2 cm-1 and 10mg 
strontium apatite at 1150.7cm-1. FTIR results clearly indicate the strong bonding 
between the Chitosan and strontium apatite. The results of  FTIR shows existence of 
carbonate group along with the peaks of other groups. This results suggested that 
strontium apatite might be formed in the composite scaffolds with some carbonate 
incorporation. 
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6. IN-VITRO DEGRADATION TEST 
Table-4: Comparison of mean initial dry weight of degradation between the 
groups    
 
Days 
Initial dry weight of degradation (MEAN±SD) 
p value 
Group-I Group-II Group-III 
1st day 9.67±2.08 7.67±1.15* 7.33±0.57* 0.04 
5th day 8.67±0.58 8.67±0.57 9.00±1.00 0.98 
9th day 10.67±0.57 13.33±2.08* 9.33±2.30# 0.04 
13th day 10.67±1.15 13.00±2.00* 9.67±1.52# 0.04 
17th day 12.33±2.88 13.00±1.00 11.33±1.15 0.12 
21st day 11.10±1.00 10.33±1.15 11.00±2.64 0.66 
26th day 11.67±1.15 9.67±2.89 10.33±4.16 0.56 
29th day 8.33±1.52 9.33±0.58 11.67±2.88 0.67 
(*p<0.05 significant compared Group-I with other groups on same time period, 
#p<0.05 significant compared Group-II with other groups at same time period)  
 
Table -4 shows Comparison of mean initial dry weight between the groups of 
degradation in PBS. Among this 1st, 9th and 13th day was statistically significant, p 
value 0.04.No statistical difference was found between other groups at 5th, 17th, 21st, 
26th and 29th day. 
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Table:5: Comparison of mean weight after degradation between the groups    
Days 
weight after degradation (MEAN±SD) 
p value 
Group-I Group-II Group-III 
1st day 9.67±2.08 7.67±1.15* 7.33±0.57* 0.04 
5th day 8.33±1.15 8.67±0.58 9.00±1.00 0.23 
9th day 8.33±0.57 12.33±1.52* 8.00±1.73# 0.04 
13th day 9.00±1.00 13.00±2.00 9.33±1.15 0.06 
17th day 9.00±1.73 10.67±0.58 9.66±1.15 0.08 
21st day 7.67±0.57 9.67±1.15 9.67±1.52 0.32 
26th day 8.00±0.00 8.00±1.73 8.33±2.51 0.56 
29th day 6.00±1.73 8.33±0.57* 2.67±4.61*,# 0.03 
(*p<0.05 significant compared Group-I with other groups on same time period, 
#p<0.05 significant compared Group-II with other groups at same time period)  
 
Table -5 shows Comparison of mean dry weight between the groups after 
degradation  in PBS. Among this 1st  ,9th and 29th day was statistically significant , 
p<0.05.No statistical difference was found between other groups at 5th ,13th ,17th, 
21st and 26th day. 
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Table-6: Comparison of mean degradation between the groups    
Days 
mean degradation (MEAN±SD) 
p value 
Group-I Group-II Group-III 
1st day 0.00±0.00 0.00±0.00 0.00±0.00 - 
5th day 0.41±0.07 0.00±0.00 0.00±0.00 0.56 
9th day 0.21±0.04 0.06±0.07* 0.13±0.02*,# 0.03 
13th day 0.15±0.05 0.00±0.00* 0.03±0.05*,# 0.03 
17th day 0.26±0.03 0.17±0.08* 0.14±0.09*,# 0.04 
21st day 0.29±0.08 0.06±0.10* 0.10±0.09*,# 0.01 
26th day 0.31±0.06 0.16±0.0* 0.17±0.73*,# 0.02 
29th day 0.28±0.08 0.10±0.06* 0.73±0.46*,# 0.03 
(*p<0.05 significant compared Group-I with other groups on same time period, 
#p<0.05 significant compared Group-II with other groups at same time period)  
 
Table 6 shows Comparison of mean degradation between the groups. Among 
this 9th,13th 17th 21st 26th and 29th  was statistically significant , p<0.05.No statistical 
difference was found between 1st and 5th day between the groups. Overall there was 
an increase in weight loss with the increase in weight of concentration of strontium 
apatite particles in composite membrane. 
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7. IN-VITRO BIOACTIVITY TEST 
Table-7: Multiple comparison of mean invitro bioactivity between the groups 
before and after 3 days in SBF. 
Groups Initial dry weight (mg) (MEAN±SD) 
Final dry weight 
(mg) 
(MEAN±SD) 
Weight difference 
(mg) 
(MEAN±SD) 
Group-I 6.67±1.15 9.00±1.00 2.33±0.57 
Group-II 8.00±1.73* 10.66±0.57* 2.66±1.15 
Group-III 7.67±0.57* 11.00±2.73* 3.00±2.64* 
(*p<0.05 significant compared Group-I with other groups, p>0.05 no significant 
compared Group-II with other groups) 
 
Table 7 shows multiple comparison of mean invitro bioactivity between the 
groups before and after 3 days in SBF. Among this group I showed least weight loss 
[2.33±0.57] when compared with other groups which was statistically significant. 
Group III showed highest weight loss [3.00±2.64] which was statistically significant 
compared to group I and no statistical difference was seen when compared to group 
II. There is no statistical difference showed for group II when compared with group I 
and group III. 
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Table-8: Multiple comparison of mean invitro bioactivity between the groups 
before and after 7days  
Groups 
Initial dry weight 
(mg) 
(MEAN±SD) 
Final dry weight 
(mg) 
(MEAN±SD) 
Weight difference 
(mg) 
(MEAN±SD) 
Group-I 5.33±0.57 7.67±0.57 2.33±0.57 
Group-II 8.33±1.15* 12.00±1.00* 3.66±0.57* 
Group-III 7.33±1.14*,# 11.00±1.00*,# 3.33±1.15* 
(*p<0.05 significant compared Group-I with other groups, #p<0.05 significant 
compared Group-II with other groups) 
 
Table 8 shows multiple comparison of mean invitro bioactivity between the 
groups before and after 7 days in SBF. Among this group I showed least weight loss 
[2.33±0.57] when compared with other groups which was not statistically 
significant. Group II showed highest weight loss [3.66±0.57] which was statistically 
significant compared with group I and no statistical difference compared to group II. 
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8. DETERMINATION OF TOXICITY 
Table-9: Mean cell viability of the groups  
Groups Treatment Cell viability (%) (MEAN±SD) 
Group-I Chitosan derivative 71.41 
Group-II Chitosan-strontium apatite Composite (7.5 mg) 85.69 
Group-III Chitosan-strontium apatite Composite (10 mg) 71.64 
 
(a) chitosan derivative 
(b) chitosan-strontium apatite Composite (7.5 mg) 
(c) chitosan-strontium apatite Composite (10 mg). 
 
Table shows Chitosan derivative membrane exhibited 71.41% cell viability. 
Among the composite membrane (chitosan derivative /strontium apatite 7.5mg) 
showed high percentage of viability(85.69%) after 24 hour. So on comparison 
composite membrane exhibited enhanced viability than chitosan derivative alone. 
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Direct contact  assay with L-929 Mouse fibroblasts at 24 hours 
(a)     (b)   
(c)  
 
MTT assay with L-929 Mouse fibroblasts at 24 hours 
(a)          (b)  
 
(c)  
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Graph-1: Comparison of mean thickness values between the groups 
 
 
 
Graph-2: Multiple comparison of mean tensile strength (mg) values between 
the groups   
 
 
 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0.5
Group-I Group-II Group-III
M
ea
n
0
0.5
1
1.5
2
2.5
3
Group-I Group-II Group-III
M
ea
n
 
(M
Pa
)
Graphs 
 
    
  
 
Graph-3: Multiple comparison of mean elongation at break (%)values between 
the groups   
 
 
 
Graph-4: Multiple comparison of mean tear strength values between the 
groups 
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Graph-5: FTIR  analysis between the groups
 
Graph-6: Comparison of mean initial dry weight of degradation between the 
groups    
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Graph-7: Comparison of mean weight after degradation between the groups    
 
 
 
Graph-8: Comparison of mean degradation between the groups    
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Graph-9: Multiple comparison of mean invitro bioactivity between the groups 
on 3 days in SBF. 
 
 
 
Graph-10: Multiple comparison of mean invitro bioactivity between the groups 
on 7days in SBF. 
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Graph-11: Mean cell viability of the groups 
 
 
60
65
70
75
80
85
90
Group-I Group-II Group-III
Pe
rc
en
ta
ge
 
(%
)
   
 
 
 
 
 
 
 
 
 
 
 
 
 
   Discussion 
Discussion 
 
   Page 41 
 
Periodontitis is an inflammatory disease of the supporting tissues of teeth 
caused by specific microorganisms or groups of specific microorganisms, resulting 
in progressive destruction of the periodontal ligament (PDL) and alveolar bone with 
an increase in probing depth, recession, or both.45 The different approaches of 
periodontal therapy are pointed toward exclusion of etiological features, modification 
of anatomical defects, prevention of spread and elimination of symptoms of disease 
and regeneration of periodontal tissues. The several regenerative surgical procedure 
have been tried for the regeneration of periodontal tissues.46 
Guided tissue regeneration is fundamentally the use of an occlusive membrane 
interfacing with the gingival connective tissue and epithelium on one side and 
periodontal ligament and alveolar bone tissues on the other side. It preserves space for 
clot stabilization and to stimulate periodontal tissue regeneration. It is created on the 
principle of exclusion of gingival connective tissue cells from the wound and 
preclusion of epithelial down growth. This method allows cells with regenerative 
potential to invade the wound site.47 Progenitor cells situated in the remaining PDL, 
adjacent alveolar bone, or blood are then accomplished to recolonize the root area and 
differentiate with the development of new bone, PDL, and cementum.48 Recent 
systematic reviews have verified the clinical advantages of guided regeneration 
procedures as opposed to conventional open-flap debridement for treating furcation 
and intrabony defects.49 Such regenerative treatments include the utilization of a 
wide variety of surgical approaches, exogenous growth factors, barrier membranes, 
a series of bone grafts and osteoconductive  materials or protein mixtures, genes 
from recombinant technology and cell-based technology. 
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Numerous barrier membranes have been established and proved as part of 
these two procedures to prevent epithelial and connective tissue cells from entering 
the deficient space, while allowing PDL cells to selectively migrate into the defect. 
 Barrier membranes should fulfil some important necessities:50 
• Biocompatibility - the associations between membranes and host tissue 
should not induce adverse effect. 
• Space-making - the ability to retain a space for cells from surrounding bone 
tissue to migrate for stable time duration.  
• Cell- occlusiveness - inhibition of fibrous tissue that delay bone formation 
from entering the defect site. 
• Mechanical strength - suitable physical properties to allow and keep the 
healing process, including protection of the underlying blood clot. 
• Degradability - suitable degradation time matching the regeneration rate of 
bone tissue to avoid a secondary surgical procedure to eliminate the 
membrane. 
First and second generation  membranes act as a physical barrier to elude 
connective and epithelial tissue down growth into the defect for supporting the 
periodontal tissue regeneration. These barriers possess many  mechanical, structural 
and bio functional restrictions. Due to the inherent limitations of nonresorbable barrier 
membranes, current research has been focused on the advance of resorbable 
membranes proper for clinical applications. The main benefit of resorbable 
membranes is avoiding a second surgical performance, which is required when non 
resorbable membranes are employed. Both natural and synthetic polymers are used 
to construct bioresorbable barrier membranes. Aquirre et al,51 showed new bone 
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formation in bony defects by using absorbable membrane. However, controlling the 
time of absorption is difficult and later could cause a localized inflammatory 
response. In addition to the above disadvantages, poor membrane stability in the wet 
state causes space loss among the tooth and the membrane, creating reduced clinical 
results. The theory of tissue engineering has established, third-generation 
membranes have developed, which not only act as barriers but also as delivery 
devices to release specific agents such as antibiotics, adhesion factors, growth 
factors,  etc., at the wound site on a time or need basis in order to coordinate and 
direct natural wound healing in a enhanced way. 
Recently, attention in chitosan has improved due to its admirable biological 
properties such as biocompatibility, antibacterial effect, and rapid healing capacity. 
Some studies advocated that chitosan improves the formation of bone tissue and it 
could be used as the matrix of tissue engineering for gingiva. Paik et al,52 reported 
that chitosan improved type I collagen synthesis in the early stage, and enabled 
differentiation into osteogenic cells in the human periodontal ligament fibroblasts in-
vitro. In addition, a chitosan/collagen sponge applied to one wall intrabony defects 
surgically created in beagle dogs inhibited the apical migration of the epithelium and 
superior the growth of new bone and new cementum.53 
               Another biomaterial of attention is hydroxyapatite, which is a major 
component of human bone. Hydroxyapatite is used as bone substitute in the fields of 
orthopaedics and dentistry because of its good bioactivity, osteoconductivity, and 
biocompatibility. It is brittle and easy to fracture so it is difficult to mould into a 
specific shape. In order to overcome the drawback of hydroxyapatite, in this study 
we use strontiumapatite ie, strontium is incorporated into hydroxyapatite. It is 
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chemically similar to mineral component of bones, can form a direct chemical bond 
with surrounding bone tissues, ,inhibition of osteoclast formation, biodegradable, 
bioactive, osteoblast differentiation and excellent healing. Studies have revealed that 
nano-HA/chitosan composite scaffolds may serve as a good 3D substrate for cell 
attachment in vitro and migration in engineered bone and periodontal tissue. 
Complexes with natural polymer like chitosan and its derivatives with bioactive 
ceramic as a hydroxyapatite contribute and increase the appropriateness and 
advances in the field of TE. Such composite materials based on biodegradable 
polymers and bioactive ceramics, are appropriate for regenerative medicine. 
In this study present study we fabricated three different GTR membrane, 
grouped as chitosan derivative, chitosan-strontium apatite composite (7.5 mg) and 
chitosan-strontium apatite composite(10 mg). Morphological analysis of fabricated 
membranes was done under SEM. Porous 3D scaffolds are commonly used in tissue 
engineering applications. The structural properties of the scaffolds, for example, 
porosity and pore size have direct implications on their functionality both in vitro 
and in vivo. Generally, interconnected porous scaffold networks that enable the 
transport of nutrients, removal of wastes, and facilitate proliferation and migration 
of cells are essential.  Previous study by Murphy, C.M et al 2010 reported that 
optimal cell proliferation and infiltration was found in CG scaffolds with mean pore 
sizes greater than 300µm.54 In addition, the ability of larger pores to aid cell 
infiltration was shown to override the beneficial effect of greater initial cell 
attachment surface areas provided by smaller pores. This study supported the 
importance of having pore sizes greater than 300µm for osteogenesis to occur. Artel 
et al 2011 showed that larger pore sizes of approximately 160 to 270µm enabled 
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angiogenesis throughout scaffold by using multi-layered agent-based model 
simulation.55 It has also been revealed that vascularization of constructs 
necessitates pores greater than 300µm. Scaffolds with pore sizes of about 20 to 1500 
µm have been used. In this study scaffolds produced from chitosan derivative 
concentration had better porous structures of pore sizes 300 µm and 500 µm under 
different magnification. With the incorporation of strontium apatite the porous 
structure of the composite scaffolds did not change significantly. Here chitosan 
derivative  and chitosan derivative/strontium apatite composite scaffolds (7.5 mg 
and 10 mg strontium apatite)  showed high porosity and good inter pore connectivity 
ie, 300 µm and 500 µm, serve to provide suitable microenvironments to support cell 
growth and function. Compared to the chitosan derivative the pore sizes of 
composite scaffolds decreased slightly. It was observed that good distribution and 
good adhesion of strontium apatite particles in the chitosan matrix were present.  
The mechanical properties of the fabricated membranes observed in the 
study included thickness, tensile strength, elongation at break and suture pull out 
strength. All the membrane exhibited statistical significant difference in mechanical 
properties within the group. Among the Comparison of mean thickness within the 
groups, composite membranes exhibited increased thickness compared with chitosan 
derivative. Graph 1 shows Comparison of mean thickness values between the 
groups. Among this group I shows least thickness compared with group II and  
group III  respectively and was statistically significant compared with other groups. 
Group III shows highest thickness and was not statistically significant with group II. 
Overall there was an increase in thickness with the increase in weight of 
concentration of strontium apatite particles in composite membrane. Among the 
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comparison of tensile strength within the groups, [graph 2] chitosan derivative 
exhibited highest tensile strength compared with composite membranes. The 
composite membrane showed a significant decrease in the tensile strength compared 
to chitosan derivative. In this study chitosan derivative /strontium apatite composite 
membrane have tensile strength 0.55±0.17MPa.The significant decrease in tensile 
strength for the composite membrane can be attributed to a great number of open 
pores. But it possess sufficient tensile strength to function as a barrier membrane. 
Previous study by Hunter KT et al. in 2013 reported hydroxyapatite–chitosan–
gelatin membranes have comparable tensile strength (0.5–10MPa) and have better or 
comparable mechanical properties and possess sufficient tensile strength to function 
as a barrier membrane.37 
Considering the elongation break or elasticity of fabricated GTR 
membrane,[Graph 3]highest elongation of break exhibited by chitosan –strontium 
apatite(7.5mg and 10mg) compared with chitosan derivative .Chitosan derivative 
[0.07±0.02] shows least elongation at break and chitosan –strontium apatite(10mg) 
shows highest[0.12±0.01] elongation at break. There was statistical difference 
between chitosan derivative with composite membranes. Overall there was an 
increase in elongation at break with the increase in weight of concentration of 
strontium apatite particles in composite membrane. 
Previous study by P. A. Norowski et al.2012, evaluated Suture pull out 
strength and in vitro fibroblast and RAW 264.7 monocyte biocompatibility of 
genipin cross linked nano fibrous chitosan mats for guided tissue regeneration. He 
concluded that ultimate suture pull out strength was significantly lower (51–67%) 
than that of commercially available collagen membranes.36  In this study, the tear 
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strength of the chitosan  derivative  membranes were less than that of composite 
membrane[graph 4] .Chitosan derivative showed least tear strength compared with 
other groups and  chitosan-strontium apatite (7.5mg) showed highest tear strength. 
Overall there was an increase in tear strength with the increase in weight of 
concentration of strontium apatite particles in composite membrane. 
Evaluating chemical stability of the  fabricated membrane by FTIR, [Graph 
5] the spectra revealed that OH-NH vibration of  chitosan alone at 3348cm-
1,chitosan derivative at 3351cm-1,  chitosan with 7.5 mg strontium apatite at 3285 
cm-1 and 10mg strontium apatite at 3294cm-1.CH vibration of CH2 and CH3: 
chitosan alone at 2919.9 cm-1,chitosan derivative at 2877.2cm-1,  chitosan with 7.5 
mg strontium apatite at 2877.4 cm-1 and 10mg strontium apatite at 2877.1 cm-
1.C=O stretching : chitosan alone at 1626.4cm-1,chitosan derivative at 1630.1cm-1,  
chitosan with 7.5 mg strontium apatite at 1633.3 cm-1 and 10mg strontium apatite at 
1639.9cm-1.C-O-C group : chitosan alone at 1149.7cm-1,chitosan derivative at 
1151.2cm-1,  chitosan with 7.5 mg strontium apatite at 1151.2 cm-1 and 10mg 
strontium apatite at 1150.7cm-1. FTIR results specify the strong bonding between 
the Chitosan and strontium apatite. The result of FTIR shows existence of carbonate 
group along with the peaks of other groups. Finding of the study suggested that 
strontium apatite might be formed in the composite scaffolds with some carbonate 
incorporation. 
In degradation analysis the composites containing strontium apatite   
experienced higher weight loss. Graph 8 shows Comparison of mean degradation 
between the groups. Among this 9th, 13th 17th 21st 26th and 29th was statistically 
significant. No statistical difference was found between 5th day between the groups. 
Discussion 
 
   Page 48 
 
Overall there was an rise in weight loss with the rise in weight of concentration of 
strontium apatite particles in composite membrane. This is associated to the 
favoured attack at the polymeric–ceramic interface resulting in leaching of strontium 
apatite to the solution. Finding from our study consistent with the study done by Tao 
Sun et al, 2014, similar results were reported for other biodegradable polymers 
reinforced with hydroxyapatite.38 Invitro bioactivity within the groups between 3 
and 7 days in SBF [Graph 13]. Chitosan derivative is least weight loss compared 
with other groups and there is no statistical difference showed between chitosan-
strontium apatite composite membranes. Overall there was an rise in weight loss 
with the rise in weight of concentration of strontium apatite particles in composite 
membrane. 
The most important requirement for the biomaterial is its biocompactibility 
in a specific environment, together with the non-cytotoxicity of its degradation 
products.as a preliminary step towards the evaluation of cyto- compactability of the 
scaffold, MTT assay was performed and result reveals the non-cytotoxicity nature of 
the tested membranes i.e, chitosan derivative, chitosan-strontium apatite 
Composite(7.5 mg) and chitosan-strontium apatite Composite(10 mg). The 
percentage of viability of cells on the membrane determine the suitability of the 
material for the intended application.in this study the potential of fabricated 
membranes for the tissue engineering applications was evaluated by invitro cell 
culture studies using L929 mouse fibroblast cell lines. The cells maintained their 
characteristics spindle morphology on all the GTR membranes after 24 hours. 
Chitosan derivative membrane exhibited 71.41% cell viability. Among the 
composite membrane (chitosan derivative /strontium apatite 7.5mg) showed high 
Discussion 
 
   Page 49 
 
percentage of viability(85.69%) after 24 hours [Graph 14]. So on comparison 
composite membrane exhibited enhanced viability than chitosan derivative alone. 
One of the limitation of the study was in cell part. Present study analysed 
only the cytotoxicity. In the future the membrane should be completely tested for 
cell studies. ie, cell adhesion, proliferation, migration, differentiation.  
This study highlights the outcome of cross-linking chitosan derivative and 
Strontium apatite and could be a potential approach to increase the morphological 
properties, mechanical strength and possess excellent degradation behaviour, in-
vitro bioactivity finally enhanced cell viability. The challenges of  TE are principally 
the physicochemical properties of the scaffold, surface chemistry and biological 
adaptation for cell culture. In line with these cross-linked chitosan derivative and 
strontium apatite scaffold are promising substrate for guided tissue regeneration 
membrane. 
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In the present study an attempt is being made to fabricate third generation 
GTR membrane for periodontal tissue engineering application.ie, chitosan derivative 
and strontium apatite of varying concentration via freeze drying technique and 
comparing their in vitro properties. All the fabricated scaffolds were highly porous 
and had interconnected pore structures. The addition of strontium apatite to chitosan 
derivative enhanced mechanical properties of composite scaffold compared to 
chitosan derivative. The composite membrane showed excellent degradation 
property and in-vitro bioactivity. There was an increase in weight loss with the 
increase in weight of concentration of strontium apatite particles in composite 
membrane. Evaluating chemical stability of the fabricated membrane by FTIR 
,shows existence of carbonate group along with the peaks of other groups suggested 
that strontium apatite might be formed in the composite scaffolds with some 
carbonate incorporation. In cell culture ;direct contact and MTT assay, the scaffolds 
showed positive response to mouse fibroblast L929 cells attachment.  
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Biomaterials consist of bioactive and  bioresorbable substances which mimic 
the natural function of bone and activate in vivo mechanisms of tissue regeneration. 
Such composite materials based on biodegradable polymers and bioactive ceramics, 
are suitable for regenerative medicine. In this present study chitosan derivative and 
chitosan derivative/strontiumapatite composite scaffolds were successfully 
fabricated and characterised. The morphological properties, mechanical properties, 
chemical properties, degradation behaviour and bioactivity of the scaffolds were 
studied. Moreover, the scaffolds showed positive response to mouse fibroblast L929 
cells attachment. Overall, the findings suggest that strontium apatite -chitosan 
derivative composite scaffolds could be suitable for use as a GTR membrane. 
Further studies are needed for chitosan derivative and strontium apatite composite 
membrane for clinical use. 
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